BenevolentAI SA BAI-NL:Euronext Amsterdam

RT Quote | Exchange | EUR
Last | 5:25 PM CEST
0.66UNCH (UNCH)
Volume
8,306
52 week range
0.48 - 2.66
Loading...
  • Open0.64
  • Day High0.66
  • Day Low0.63
  • Prev Close0.66
  • 52 Week High2.66
  • 52 Week High Date12/28/23
  • 52 Week Low0.48
  • 52 Week Low Date12/20/23

Key Stats

  • Market Cap91.34M
  • Shares Out124.44M
  • 10 Day Average Volume9,302.67
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-38.89

KEY STATS

  • Open0.64
  • Day High0.66
  • Day Low0.63
  • Prev Close0.66
  • 52 Week High2.66
  • 52 Week High Date12/28/23
  • 52 Week Low0.48
  • 52 Week Low Date12/20/23
  • Market Cap91.34M
  • Shares Out124.44M
  • 10 Day Average Volume9,302.67
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-38.89

RATIOS/PROFITABILITY

  • EPS (TTM)-0.62
  • P/E (TTM)-1.07
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BenevolentAI SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BenevolentAI SA is an artificial intelligence (AI)-enabled drug discovery and development company. Through the combined capabilities of this AI platform, its scientific expertise, and wet-lab facilities, it delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers its in-house drug pipeline and supports collaborations with AstraZeneca, as well as research and charitable...
Francois Nader M.D.
Chairman of the Board
Joerg Moeller M.D., Ph.D.
Chief Executive Officer, Executive Director
Catherine Isted
Chief Financial Officer
Address
4-8 Maple Street
London
W1T 5HD
United Kingdom